In 2024, Teoresi Group launched the MedTech division, which is the result of Teoresi's sustained investment in Lifesciences and the acquisition of MediCon Ingegneria (Bologna) in 2023. Teoresi MedTech stems from Medicon s extensive expertise, accumulated over more than two decades of pioneering rese...